BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29902443)

  • 41. Membrane undulation induced by NS4A of Dengue virus: a molecular dynamics simulation study.
    Lin MH; Hsu HJ; Bartenschlager R; Fischer WB
    J Biomol Struct Dyn; 2014; 32(10):1552-62. PubMed ID: 23964591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hsp90 interacts with multiple dengue virus 2 proteins.
    Srisutthisamphan K; Jirakanwisal K; Ramphan S; Tongluan N; Kuadkitkan A; Smith DR
    Sci Rep; 2018 Mar; 8(1):4308. PubMed ID: 29523827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell fusing agent virus and dengue virus mutually interact in Aedes aegypti cell lines.
    Zhang G; Asad S; Khromykh AA; Asgari S
    Sci Rep; 2017 Jul; 7(1):6935. PubMed ID: 28761113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.
    Miorin L; Laurent-Rolle M; Pisanelli G; Co PH; Albrecht RA; García-Sastre A; Morrison J
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.
    Shan C; Xie X; Zou J; Züst R; Zhang B; Ambrose R; Mackenzie J; Fink K; Shi PY
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host Factor SPCS1 Regulates the Replication of Japanese Encephalitis Virus through Interactions with Transmembrane Domains of NS2B.
    Ma L; Li F; Zhang JW; Li W; Zhao DM; Wang H; Hua RH; Bu ZG
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation.
    Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
    Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
    J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A new human cellular protein AUP1. I. In vitro interaction of AUP1 with adenoviral proteins E4ORF3 and E1A].
    Karpisheva KV; Tauber B; Kisliakova TV; Dobner T
    Tsitologiia; 2002; 44(9):830-8. PubMed ID: 12534236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary structure and membrane topology of dengue virus NS4A protein in micelles.
    Li Y; Lee MY; Loh YR; Kang C
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):442-450. PubMed ID: 29055659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reciprocal Effects of Fibroblast Growth Factor Receptor Signaling on Dengue Virus Replication and Virion Production.
    Cortese M; Kumar A; Matula P; Kaderali L; Scaturro P; Erfle H; Acosta EG; Buehler S; Ruggieri A; Chatel-Chaix L; Rohr K; Bartenschlager R
    Cell Rep; 2019 May; 27(9):2579-2592.e6. PubMed ID: 31141684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploitation of cellular pathways by Dengue virus.
    Fischl W; Bartenschlager R
    Curr Opin Microbiol; 2011 Aug; 14(4):470-5. PubMed ID: 21798792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleocytoplasmic Trafficking of Dengue Non-structural Protein 5 as a Target for Antivirals.
    Jans DA; Martin AJ
    Adv Exp Med Biol; 2018; 1062():199-213. PubMed ID: 29845535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NS4/5 mutations enhance flavivirus Bamaga virus infectivity and pathogenicity in vitro and in vivo.
    Colmant AMG; Bielefeldt-Ohmann H; Vet LJ; O'Brien CA; Bowen RA; Hartwig AE; Davis S; Piyasena TBH; Habarugira G; Harrison JJ; Hobson-Peters J; Hall RA
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008166. PubMed ID: 32203536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of viable TAP-tagged dengue virus for investigation of host-virus interactions in viral replication.
    Poyomtip T; Hodge K; Matangkasombut P; Sakuntabhai A; Pisitkun T; Jirawatnotai S; Chimnaronk S
    J Gen Virol; 2016 Mar; 97(3):646-658. PubMed ID: 26669909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-21 promotes dengue virus serotype 2 replication in HepG2 cells.
    Kanokudom S; Vilaivan T; Wikan N; Thepparit C; Smith DR; Assavalapsakul W
    Antiviral Res; 2017 Jun; 142():169-177. PubMed ID: 28365456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-virus tracking approach to reveal the interaction of Dengue virus with autophagy during the early stage of infection.
    Chu LW; Huang YL; Lee JH; Huang LY; Chen WJ; Lin YH; Chen JY; Xiang R; Lee CH; Ping YH
    J Biomed Opt; 2014 Jan; 19(1):011018. PubMed ID: 24192777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infection with flaviviruses requires BCLXL for cell survival.
    Suzuki T; Okamoto T; Katoh H; Sugiyama Y; Kusakabe S; Tokunaga M; Hirano J; Miyata Y; Fukuhara T; Ikawa M; Satoh T; Yoshio S; Suzuki R; Saijo M; Huang DCS; Kanto T; Akira S; Matsuura Y
    PLoS Pathog; 2018 Sep; 14(9):e1007299. PubMed ID: 30261081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.